Skip to main content

Table 5 Treatment outcomes of resectional surgery for NTM lung disease in previous reports published between 1994 and 2014

From: Treatment outcomes of adjuvant resectional surgery for nontuberculous mycobacterial lung disease

Author, year, reference

Study period

No. of Patients (No. of Resections)

Common etiology (No.)

Sputum culture conversion rate (%)

Long-term relapse rate (%)

Postoperative mortality/morbidity (%)

Pomerantz, 1996 [12]

1983-1996

13 (15)

MAC (12)

100

8

0/8

Ono, 1997 [13]

1991-1996

8 (8)

MAC (8)

100

13

0/0

Shiraishi, 1998 [14]

1979-1996

33 (33)

MAC (33)

94

6

0/15

Nelson, 1998 [15]

1989-1997

28 (28)

MAC (28)

79

4

7/29

Shiraishi, 2002 [16]

1993-2001

21 (21)

MAC (21)

100

10

0/29

Shiraishi, 2004 [17]*

1983-2002

11 (11)

MAC (10), MABC (1)

100

9

18/36

Sherwood, 2005 [18] †

1994-2003

26 (26)

MAC (15), MABC (1)

82

0

23/46

Watanabe, 2006 [19]

1990-2005

22 (25)

MAC (22)

100

5

0/5

Koh, 2008 [20]

2002-2006

23 (23)

MAC (10), MABC (12)

91

0

4/35

Mitchell, 2008 [21]

1983-2006

236 (265)

MAC (189), MABC (32)

NA

NA

3/12

van Ingen, 2010 [22]

2000-2009

8 (8)

MAC (7)

88

0

13/50

Yu, 2011 [23]

2004-2009

134 (172)

MAC (118), MABC (14)

84

7

0/7

Jarand, 2011 [7]

2001-2008

24 (29)

MABC (24)

57

NA

17/25

Mitchell, 2012 [24]

2004-2010

171 (212)

MAC (147), MABC (36)

NA

NA

0/9

Shiraishi, 2013 [25]

2007-2011

60 (65)

MAC (55), MABC (3)

100

3

0/12

This study

2007-2013

70 (74)

MAC (45), MABC (23)

81

0

1/20

  1. NTM, nontuberculous mycobacteria; MAC, Mycobacterium avium complex; MABC, Mycobacterium abscessus-massiliense complex; NA, not available.
  2. *All patients underwent pneumonectomy.
  3. †All patients underwent completion pneumonectomy.